A number of companies are using the lessons and technologies of traditional genomics--the microarray chief among them--to delve into the more challenging world of functional genomics and proteomics.
Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results